| Domain |
Quality Indicator |
Facility |
State |
Facility rank
(#1 is best) |
| For the Quality Indicators below, a lower percentage is better. |
| Psychosocial |
Worsening or serious resident behavior problems (LS) |
9.6% |
8.4% |
216 of
326 |
| Psychosocial |
Prevalence of depressive symptoms (LS) |
0.6% |
4.1% |
61 of
325 |
| Quality of Life |
Prevalence of physical restraints (LS) |
0.0% |
0.0% |
1 of
326 |
| Continence |
Worsening or serious bowel incontinence (LS) |
42.9% |
30.5% |
289 of
326 |
| Continence |
Worsening or serious bladder incontinence (LS) |
45.4% |
29.9% |
286 of
326 |
| Continence |
Prevalence of occasional to full bowel incontinence without a toileting plan (LS) |
99.1% |
93.9% |
143 of
314 |
| Continence |
Prevalence of occasional to full bladder incontinence without a toileting plan (LS) |
92.5% |
84.8% |
240 of
318 |
| Continence |
Prevalence of indwelling catheter (LS) |
1.5% |
2.3% |
153 of
326 |
| Infections |
Prevalence of urinary tract infections (LS) |
7.6% |
2.9% |
312 of
326 |
| Infections |
Prevalence of infections (LS) |
1.2% |
2.4% |
116 of
324 |
| Accidents |
Percent of residents experiencing one or more falls with major injury (LS) |
1.1% |
0.7% |
250 of
326 |
| Nutrition |
Prevalence of unexplained weight loss (LS) |
6.0% |
4.3% |
252 of
326 |
| Skin Care |
Prevalence of pressure sores in high risk residents (LS) |
7.3% |
5.1% |
265 of
322 |
| Psychotropics |
Prevalence of anti-psychotics without a diagnosis of psychosis (LS) |
3.3% |
9.0% |
60 of
321 |
| Functioning |
Worsening or serious functional dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious mobility dependence (LS) |
n/a |
|
n/a of
0 |
| Functioning |
Worsening or serious range of motion limitation (LS) |
11.0% |
13.2% |
157 of
323 |
| Pain |
Percent of residents who self-report moderate to severe pain (LS) |
7.3% |
14.7% |
69 of
325 |
| For the Quality Indicators below, a higher percentage is better. |
| Functioning |
Walking as well or better than on a previous assessment (LS) |
n/a |
|
n/a of
0 |
| (Date range:
October 1, 2023 to September 30, 2024) |
Contact Us
